GlassScriptPhysician profile
Ricky P Tang
NPI 1154305639
$935.04
in general payments reported to CMS, 2019-2025
15 companies · $143 in 2025
The $143 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $76.38 · 2020: $27.43 · 2022: $245 · 2023: $188 · 2024: $255 · 2025: $143.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $587.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $586.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $290.63 | 2022-2023 | |
| Abbott Laboratories | $188.36 | 2023-2025 | Freestyle Libre 3, Thoratec Heartmate 3 Lvas Implant Kit |
| Astellas Pharma US INC | $81.69 | 2023-2025 | Veozah, Xtandi |
| E.R. Squibb & Sons, L.L.C. | $68.00 | 2022-2023 | Eliquis |
| Novo Nordisk INC | $45.59 | 2024 | Rybelsus, Ozempic |
| Irhythm Technologies, INC. | $42.17 | 2024 | Zio Xt Patch, Zio Monitor |
| Astrazeneca Pharmaceuticals LP | $36.39 | 2019-2024 | Farxiga |
| Amgen INC. | $31.69 | 2025 | Otezla, Repatha |
| Regeneron Healthcare Solutions, INC. | $31.07 | 2025 | Dupixent |
| Amarin Pharma, INC. | $27.43 | 2020 | |
| Janssen Pharmaceuticals, INC | $23.77 | 2019 | |
| Optinose US, INC. | $21.53 | 2019 | |
| Glaxosmithkline, LLC. | $16.17 | 2022 | |
| Baxter Healthcare | $15.52 | 2025 | Hillrom - Monarch Airway Clearance System |
| Merck Sharp & Dohme LLC | $15.03 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ricky Tang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.